Rhumbline Advisers »

Zentalis Pharmaceuticals shares owned by Rhumbline Advisers

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Rhumbline Advisers from 13F filings

Historical chart of Rhumbline Advisers investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Rhumbline Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.2M 81k 15.15
2023-09-30 $1.6M 81k 20.06
2023-06-30 $1.9M 67k 28.21
2023-03-31 $1.1M 65k 17.20
2022-12-31 $1.2M 58k 20.15
2022-09-30 $1.2M 55k 21.66
2022-06-30 $1.3M 46k 28.11
2022-03-31 $1.7M 38k 46.15
2021-12-31 $3.0M 35k 84.07
2021-09-30 $2.3M 35k 66.64
2021-06-30 $1.7M 32k 53.21
2021-03-31 $1.3M 31k 43.39
2020-12-31 $1.7M 33k 51.95
2020-09-30 $396k 12k 32.70
2020-06-30 $631k 13k 48.02